Financials
- Market Capitalization 477.32 M
- Employee 116
- Founded 2013
- CEO Shankar Musunuri
- Website www.ocugen.com
- Headquarter Delaware, United States
- FIGI BBG00194VJB1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.87
Relación precio/flujo de caja
91.83
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2935 | NVCT Nuvectis Pharma, Inc. - Common Stock | 18.44 USD | +0.49% | -6.73% | +68.56% | +120.31% | 489.13 M USD | ||
| 2938 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.61 USD | -8.52% | -21.08% | -3.01% | -22.60% | 486.32 M USD | ||
| 2960 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.77 USD | -8.48% | -14.99% | -5.47% | +75.79% | 472.38 M USD | ||
| 2961 | VSTM Verastem, Inc. - Common Stock | 5.37 USD | -2.89% | +19.60% | +29.09% | +7.83% | 471.88 M USD |